CPHbiomedix ApS
CVR 43118676 · Private limited company (ApS) · Active · Low risk
CPHbiomedix ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 3.6m and a net result of DKK -22k. CEO: Claus Bo Vöge Christensen.
Bankruptcy risk for CPHbiomedix ApS
0.0 × the average (1.41%) · higher risk than 18% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 43118676
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (4 years)
- Address
- Rosendalsgade 8, kl. tv
2100 København Ø - Municipality
- København
- Industry
- Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990)
Bankruptcies in the industry: Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. - Share capital
- DKK 40k
- Auditor
- Kallermann Revision A/S - statsautoriseret revisionsfirma
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 4 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 98.9% |
| Current ratio | 6,426% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 3 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 474k | DKK 1.1m | DKK 1.3m |
| Net profit | DKK -22k | DKK 237k | DKK 279k |
| Equity | DKK 3.6m | DKK 3.6m | DKK 3.3m |
| Total assets | DKK 3.6m | DKK 3.8m | DKK 3.6m |
| Cash | DKK 254k | DKK 593k | – |
| Short-term debt | DKK 41k | DKK 212k | – |
| Avg. employees | 1 | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Kallermann Revision A/S - statsautoriseret revisionsfirma.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 98 | ||
| 1 Jan 2024 – 31 Dec 2024 | 50 | ||
| 1 Jan 2023 – 31 Dec 2023 | 64 | ||
| 1 Jan 2022 – 31 Dec 2022 | 74 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Claus Bo Vöge Christensen | Current | |
| Owner (100%) | Claus Bo Vöge Christensen | Current | |
| Founder | Claus Bo Vöge Christensen | Current |
The CEOs' other companies
Claus Bo Vöge Christensen – 6 other companies
- ACARIX A/S Active
- AUSCULTO ApS Active
- Beasty Cider ApS Opløst
- Universal Monkeys ApS Active
- XENOGENIX ApS Opløst
- XENOGENIX HOLDING ApS Compulsorily dissolved
Address history (1 moves)
| Rosendalsgade 8, kl. tv, 2100 København Ø | |
| Ryvangs Allé 81, 2900 Hellerup |
Other companies at the same address
- SØD MUSIK ApS Bankrupt
- WINNER MARKETING ApS Bankrupt
- CITY OFFICE ApS Compulsorily dissolved
Similar companies in København
- SCANDINAVIAN MODELS A/S København Ø
- LARSEN & BIRKEHOLM A/S SKANDINAVISK PATENTBUREAU København V
- P.K. CONSULT ApS København Ø
- NYKREDIT MÆGLER A/S København K
- Journey House ApS København K
- IP-Safe Benelux ApS København K
- Faurby & Ernst ApS København K
- Genesis Biopharma Denmark ApS København V
- CE Consult ApS København K
- NTS Analytica ApS Vanløse
- 4 PLYRS ApS København S
- idearlify ApS København S
Questions and answers about CPHbiomedix ApS
Has CPHbiomedix ApS gone bankrupt?
No, CPHbiomedix ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of CPHbiomedix ApS?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of CPHbiomedix ApS?
Claus Bo Vöge Christensen is the CEO of CPHbiomedix ApS.
Who is the auditor of CPHbiomedix ApS?
CPHbiomedix ApS most recently used Kallermann Revision A/S - statsautoriseret revisionsfirma.
When was CPHbiomedix ApS founded?
CPHbiomedix ApS was founded on 11 March 2022.
What is the equity of CPHbiomedix ApS?
Equity was DKK 3.6m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.